Menopause Dietitian for Women on GLP-1

A menopause dietitian for women on GLP-1 medication should be an RD or RDN who can protect nutrition, strength, and bone while coordinating with the prescriber who owns the drug. Gennev is the clearest menopause-trained integrated clinic; Berry Street pairs FDA-approved GLP-1 prescribing with an RDN. Among fixed per-visit cash prices, Gennev publishes $119 follow-ups and $199 initial dietitian visits.

Best for / not for you

Answer capsule: Start here when a smaller appetite, side effects, muscle or bone concerns, or a coverage renewal has exposed a gap your prescriber is not filling. This page is not a substitute for medical evaluation, and a dietitian is not the right first call for severe symptoms, postmenopausal bleeding, dehydration, or active eating-disorder risk.

Start here if	You are taking a GLP-1 or starting one, you are in perimenopause or menopause, and nobody managing the prescription has built a real nutrition plan around the smaller amount you can eat.
Start here if	You need an RD or RDN who understands muscle, bone, gastrointestinal tolerance, weight history, and the documentation your prescriber or insurer may need.
Not for you if	You have not started a GLP-1 and are still deciding whether weight-care medication belongs in the plan. Read Midlife Weight Care and GLP-1s in Menopause.
Not for you if	Your main question is nutrition coverage rather than GLP-1 care. Read the insurance section on this page.
See a clinician first if	You have severe or persistent abdominal pain, repeated vomiting, signs of dehydration, new bleeding after menopause, or rapid unintended weight loss.
Use a specialist route if	Appetite suppression, weighing, food tracking, or intentional weight loss could reactivate an eating disorder. Read the safety section before booking.

Fast numbers: Gennev publishes $199 for an initial dietitian visit and $119 for a follow-up. Nourish publishes $145 per self-pay session. Health Loft publishes $156. Fay says an uncovered visit could be closer to $150. Culina Health publishes memberships at $99, $169, and $229 per month. Sesame shows the current price beside each clinician before booking. Insurance may reduce the bill, but no platform can settle your cost without your exact plan.

You clicked because something scared you.

Probably a headline about muscle loss. Maybe your weight stalled while your clothes kept changing. Maybe the food noise quieted so completely that eating enough became work. Maybe a renewal letter landed and you suddenly realized nobody had been documenting the part your insurer calls “lifestyle support.”

Here is what is true, in plain terms.

The muscle-loss worry is real, but lean mass is not the same thing as muscle and the most frightening number on social media leaves that out. The bone question deserves more attention than it gets because of when this is happening to you. And the insurance door may be wider than it was before your GLP-1 prescription — but the diagnosis, network, referral rules, and plan document still decide whether it opens.

There is also a question hiding in your medicine cabinet that neither your prescriber nor your menopause clinician may have raised: whether delayed stomach emptying changes the way an oral hormone is absorbed. The answer is not the same for tirzepatide, injectable semaglutide, oral Wegovy, and the newly approved oral GLP-1 Foundayo. We read the current labels and separated what is known from what is not.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Affiliate disclosure: We may earn a commission if you use some provider links on this page. That does not change what we verify, which limitations we publish, or which option we say fits. Nobody pays us for a better position. On this page, the two strongest integrated answers — Gennev and Berry Street — are not affiliate partners.

Which menopause dietitian for women on GLP-1 should you choose?

Answer capsule: Choose Gennev when you want a menopause-trained doctor and RDN inside one weight-management clinic. Choose Berry Street when an insurance-based program that prescribes only FDA-approved GLP-1 medications and includes an RDN is the cleaner fit. If your prescriber is already responsive, Nourish, Fay, Health Loft, Culina Health, or Sesame may be enough.

We checked each company’s current service pages, prices, insurance language, credential model, and cancellation terms on September 1–3, 2026. “Prescribes” means the company publicly offers a prescribing pathway; it never means a prescription is guaranteed. “Menopause-specific” means the company expressly publishes menopause training or a menopause care pathway, not that every clinician has the same experience.

Provider-stated information plus The HRT Index editorial conclusions. Last verified September 2026. Confirm the assigned clinician, state authorization, plan eligibility, and member cost before booking.

Option	Prescribing pathway	Registered dietitian service	Menopause fit	Insurance / cash model	Current published price	The HRT Index conclusion
Gennev	Yes; its weight-management clinic prescribes GLP-1s when medically appropriate	Yes; initial RDN visit, follow-ups, labs, and doctor handoff	Explicitly menopause-trained doctors and RDNs	Most Aetna, Anthem, and UnitedHealthcare plans; self-pay available; company says clinicians are licensed or credentialed in all 50 states and DC	RDN $199 initial / $119 follow-up; doctor $250 initial / $199 follow-up	Clearest menopause-trained integrated route
Berry Street	Yes; clinicians prescribe FDA-approved GLP-1 medications only	Yes; an RDN is built into its GLP-1 program	Menopause-experienced RDNs are searchable, but the company does not say the entire GLP-1 team is menopause-trained	Insurance-based, no membership fee; current program says available in all 50 states	Member cost and medication cost depend on plan, diagnosis, deductible, prior authorization, pharmacy, and savings eligibility	Strongest insurance-first FDA-approved medication + RDN route
Nourish	No prescribing pathway located	Yes; separate menopause and GLP-1 pathways	Menopause pathway published	Large insurance network; self-pay and superbills available; company says RDNs are available in all 50 states	$145 per self-pay session	Best predictable self-pay price with a billing-denial guarantee
Fay	No prescribing pathway located	Yes; every bookable provider is presented as an RD or RDN	Menopause and GLP-1 directories published	Insurance marketplace; instant estimate tool; company says it serves all 50 states	Uncovered care could be closer to $150 per session	Best for browsing named RDNs before committing
Health Loft	No prescribing pathway located	Yes	Lists menopause/perimenopause and GLP-1 support	In-network with many non-HMO plans; does not accept Medicaid; self-pay available; company says its dietitians are licensed in almost every state	$156 per session	Straightforward RDN route if its network and state footprint fit
Culina Health	No prescribing pathway located	Yes; membership model	Publishes hormone-health and sustainable-weight-loss care, but not an integrated menopause prescriber	Self-pay membership or separate insurance route; company says it sees patients in all 50 states	$99 / $169 / $229 per month	Best when you want recurring RDN time and will use every monthly session
Sesame	Some marketplace clinicians may prescribe, but this nutrition listing is not an integrated GLP-1 program	Mixed marketplace: RDs/RDNs appear beside other clinician types	No menopause-trained network claim	Cash marketplace; price shown before booking	Varies by clinician and renders on the live listing	Best for speed only if you filter by credential yourself

Source: Gennev,^[1] Berry Street,^[2] Nourish,^[3] Fay,^[4] Health Loft,^[5] Culina Health,^[6] and Sesame.^[7]

The answer changed when Berry Street launched its integrated pathway

There are now two US programs that publicly sell prescribing and RDN care together. They are not the same program.

Gennev remains the clearest menopause-trained integrated model we found. Its public pathway starts with a 50–55 minute RDN visit, recommends six care visits over three months for behavior-change support, orders metabolic labs at intake and every six months, and hands the record to a doctor trained in obesity medicine. It explicitly says its doctors and RDNs are trained in menopause and weight management.^[1]

Berry Street now sells a second integrated path. Its clinicians prescribe FDA-approved GLP-1 medications, its program includes an RDN, it bills insurance, and it publishes availability in all 50 states. That means the honest answer is no longer “one clinic.” It is two different integrated models:

• Gennev when menopause-specific clinical training is the non-negotiable.
• Berry Street when insurance access and an FDA-approved-only formulary are the non-negotiables.

That distinction is more useful than forcing one universal winner.

And our highest-paying partner still cannot help you here

Winona is our highest-paying partner in this comparison, and it does not answer this search. We found no GLP-1 prescribing pathway and no separately bookable dietitian service in its current public care model. Winona may fit a woman seeking menopause hormone care. It is not a menopause + GLP-1 nutrition program.

We are telling you that before any affiliate CTA because this page has one job: get you into the right appointment, not the most profitable link.

Midi Health covers the hormone-and-prescriber half, not the RDN half

Midi is relevant when menopause symptoms and weight-care prescribing need to be handled together. Its current weight-management page says a care plan may include GLP-1 medication, labs, hormone prescriptions, and lifestyle guidance; visits are $250 self-pay for the first appointment and $150 for returns, with many commercial PPO plans accepted.^[8]

We did not locate a separately bookable RD or RDN appointment on Midi’s current weight-management or pricing pages. Treat it as the clinician/prescriber half of a two-provider team unless Midi confirms otherwise at intake.

Midi publishes both brand-name and compounded GLP-1 options. Compounded medications are not FDA-approved, and FDA does not review them before marketing for safety, effectiveness, or quality the way it reviews approved drugs. They are a separate category, not an interchangeable or “generic” version of an FDA-approved medication.^[9]

If this is your situation, start here

Answer capsule: Your first appointment turns on three facts: whether you already have a responsive prescriber, whether menopause symptoms need treatment in the same clinical plan, and whether you need insurance or speed. The best route is the one that closes the missing half of your care rather than selling you a second version of something you already have.

Your situation	Start with	Why
You want a menopause-trained doctor, RDN, labs, and GLP-1 prescribing in one clinic	Gennev	It publishes the strongest menopause-specific integrated model, with separate RDN and physician visits
You want an insurance-based program that combines an RDN with FDA-approved GLP-1 prescribing	Berry Street	It publishes an integrated clinician + RDN pathway, no membership fee, and an FDA-approved-only formulary
You already trust your prescriber and want predictable self-pay nutrition care	Nourish	$145 per session and a published billing guarantee if an insurance claim is denied
You want to choose a named RDN from a directory before booking	Fay	All bookable providers are presented as RDs/RDNs, with an insurance estimate tool
You want a conventional 55-minute RDN visit and Health Loft is in network	Health Loft	$156 self-pay, with current menopause/perimenopause and GLP-1 support categories
You want recurring RDN sessions and will reliably use them	Culina Health	Its membership can reduce the effective session cost, but unused visits do not roll over
You need a fast cash conversation and can verify credentials yourself	Sesame	Price and availability are visible before booking, but the nutrition results mix dietitians with other clinicians
Your hormone symptoms are the bigger half and nutrition can stay separate	Midi Health + an RDN network	Midi can handle menopause and weight-care prescribing; book nutrition separately
You use Medicaid	Verify a local or plan-contracted route first	Nourish and Health Loft currently say they do not accept Medicaid; Midi says it cannot accept Medicaid or Medi-Cal
You have Medicare	Start with the Medicare rules, not a cash marketplace	Original Medicare MNT has narrow qualifying diagnoses and referral rules
You have any history of disordered eating	Read the safety section before booking anything	The intake questions, tracking rules, and clinician’s eating-disorder competence matter more than the logo

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

Do you actually need a menopause dietitian if you are on a GLP-1?

Answer capsule: Not every woman needs a separate dietitian, but the fit is strong when appetite suppression, nausea, constipation, food aversion, rapid loss, low intake, muscle concerns, bone risk, or an eating-disorder history makes “eat better” too vague. A 2025 four-society advisory names RDN counseling as one useful support strategy — not a universal requirement.

In May 2025, the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society published a joint clinical advisory called Nutritional Priorities to Support GLP-1 Therapy for Obesity.^[10]

Four societies do not co-publish across four journals over a small point.

The advisory names the real-world problems: gastrointestinal side effects, altered food preferences and intake, nutrient shortfalls, loss of muscle and bone mass, unequal access, low long-term adherence, and weight regain after treatment stops. It recommends baseline assessment of usual eating patterns, emotional triggers, disordered eating, strength, function, and body composition, then ongoing work to manage symptoms, prevent deficiencies, and preserve muscle and bone through resistance training and an appropriate diet.^[10]

Registered dietitian counseling is one of the supportive strategies it lists. That is not the same as saying every person on a GLP-1 must hire an RDN. The useful test is simpler:

Do you have a nutrition problem your prescriber’s fifteen-minute follow-up is not solving?

What the job actually is

The prescription is already doing the “eat less” part. That job is taken.

The job that is open is making the smaller amount you eat carry more, so you come out the other side of this smaller and stronger rather than smaller and more fragile. That usually means four things:

• Enough usable nutrition inside a smaller appetite.
• A resistance-training plan that fits your current strength, joints, injuries, and access.
• A way to eat through nausea, early fullness, constipation, reflux, or food aversion without pretending those symptoms are trivial.
• A floor for fluid, vitamins, minerals, and overall intake when appetite disappears.

Menopause already puts muscle and bone on the list. Eating less puts them in bold.

Why “just eat more protein” is not the help you were given

Because it is directionally correct and practically useless without knowing the person.

We are not going to publish a universal protein target for menopausal women on GLP-1 medication. No single number can account for body size, kidney function, activity, current intake, illness, dose stage, tolerance, dietary pattern, or a history of restrictive eating. The right number also has to fit inside food you can actually keep down.

Our house rule, and we apply it site-wide: The HRT Index does not publish calorie targets, universal gram counts, meal plans, or goal weights. Not because the numbers do not matter. Because your number depends on information a responsible clinician has to collect first. Anyone who gives it to you before asking those questions is guessing at your expense.

What a dietitian can and cannot do

An RD or RDN can assess dietary intake, make a nutrition diagnosis, deliver medical nutrition therapy within her scope, help manage ordinary food-and-fluid problems around treatment, and communicate with your care team.

Acting only in the dietitian role, she does not own your medication prescription or dose. She generally does not diagnose the medical cause of severe symptoms, decide whether hormone therapy is appropriate, or promise that an insurer will cover a service. Some dietitians hold additional licenses or credentials; that second role must be stated plainly.

And she cannot treat hot flashes with a food plan. The Menopause Society’s 2023 nonhormone position statement does not recommend dietary modification, soy foods, soy extracts, or equol as treatments for vasomotor symptoms.^[11]

That is a narrow conclusion about hot flashes and night sweats, not a verdict that nutrition does not matter. But several nutrition businesses use hot flashes as a marketing headline. If flushing and night sweats are the main problem, food is not the lever they should sell you.

Who actually offers menopause + GLP-1 nutrition care?

Answer capsule: Seven online routes are credible enough to compare, but they are not seven versions of the same service. Gennev and Berry Street integrate prescribing with RDN care. Nourish, Fay, Health Loft, and Culina Health are dietitian-first. Sesame is a fast cash marketplace whose current “nutritionist” results include both dietitians and non-dietitians.

Gennev: the menopause-trained integrated route

Punchline: Gennev is the strongest answer when you want the menopause context inside the same clinic as the RDN and GLP-1 prescriber.

Its current pathway is unusually specific:

• You can self-refer, subject to insurance requirements.
• The first visit is with an RDN for 50–55 minutes.
• The company recommends six care visits over three months for behavior-change support.
• It publishes metabolic labs at intake and every six months.
• A doctor appointment follows; if medication is prescribed, it expects at least two doctor follow-ups per year.
• It says its doctors and RDNs are trained in menopause and weight management.
• It prescribes Wegovy and Zepbound when appropriate and does not guarantee a prescription.
• It does not treat diabetes in this program.^[1]

The damaging admission: Gennev is not cheap when you need both clinicians. A self-pay first RDN visit is $199 and a first doctor visit is $250. That is $449 before medication, follow-up care, or any lab cost your plan does not cover. That number is calculated from Gennev’s own current price list. Insurance may change it, but “integrated” does not mean “one bundled price.”

Its cancellation policy is also real friction: cancel or reschedule inside 24 hours and Gennev says it charges $100.^[12]

Best for: a woman who wants one chart, explicit menopause training, an RDN-first intake, labs, and a prescriber who reads the dietitian’s work.

Not for you if: your insurer is outside its listed networks, you need diabetes management inside the program, or the two-appointment self-pay entry cost is too high.

Berry Street: the insurance-first FDA-approved route

Punchline: Berry Street is the cleanest integrated route when you want an RDN and prescriber together but do not want compounded medication in the formulary.

Its current GLP-1 page says:

• Berry Street clinicians prescribe the medication and send it to the pharmacy.
• An RDN supports muscle protection, side-effect management, and the nutrition plan.
• It prescribes FDA-approved GLP-1 medications only.
• It accepts 1,250+ insurance plans and publishes availability in all 50 states.
• There is no membership fee.
• Appointment and medication costs depend on plan, formulary, diagnosis, deductible, copay, prior authorization, pharmacy, and savings-program eligibility.^[2]

Berry Street advertises visits “as low as $0” and medication “as low as $25 a month.” Those are conditional marketing numbers, not a price quote. The company itself says they are not guaranteed.^[2]

The damaging admission: Berry Street is less transparent than Gennev about the cash fallback. It does not publish one dietitian-only self-pay rate or one universal member price for the full GLP-1 pathway. You have to complete its eligibility and benefit process to learn what your plan does.

Best for: a woman whose priority is an insurance-based clinician + RDN program using FDA-approved GLP-1 medications only.

Not for you if: you want a published self-pay total before entering insurance details, or you need the whole clinical team to make an explicit menopause-training claim.

Nourish: the predictable self-pay and billing-guarantee route

Punchline: Nourish is the easiest dietitian-first choice to price when your prescriber is already doing her job.

Nourish publishes $145 per self-pay session. It also publishes a billing guarantee: if an appointment is denied, it says it will not charge for appointments that already occurred; if the actual copay or coinsurance is higher than the estimate, it limits prior-visit charges to the estimate and applies the real amount going forward.^[3]

Its own FAQ says 94% of in-network patients pay $0. That denominator matters. It is not a claim that 94% of every person who applies pays nothing.

The cancellation window matters too: changing an appointment less than 24 hours before it starts triggers a $75 fee.^[13] Nourish currently does not accept Medicaid.^[14]

Best for: an insured or self-pay woman who already has a prescriber and wants a broad RDN network, separate menopause and GLP-1 pathways, a fixed cash price, and more billing protection than most competitors publish.

Not for you if: you need the RDN and prescriber in one clinic, you use Medicaid, or you need a company that can change the medication plan.

Fay: the browsable RDN marketplace

Punchline: Fay wins when choosing the individual dietitian matters more than choosing a centralized clinic.

Fay says every provider on its platform is an RD or RDN and that it works across more than 700 insurance plans. Its price tool says care can be as low as $0 with insurance; without coverage, the company says a visit could be closer to $150.^[4]

The phrase is closer to $150, not “up to $150.” That distinction matters because it is still an estimate, not a cap.

Fay’s financial policy says the patient remains responsible for uncovered charges. Its cancellation policy applies a $75 fee when a visit is canceled inside 24 hours or when the patient arrives more than halfway through the scheduled appointment.^[15]

Best for: someone who wants to browse names, specialties, states, and availability before choosing an RDN.

Not for you if: you want the platform itself to own prescribing, or you want a guaranteed final price before the insurer adjudicates a claim.

Health Loft: the straightforward 55-minute RDN route

Punchline: Health Loft is a conventional insurance-billing RDN practice with a clearly published cash fallback.

It lists menopause/perimenopause and GLP-1 support among the conditions its dietitians work with. Its current billing FAQ publishes a $156 self-pay rate, says it is in network with many major insurers, and says it does not accept HMO plans or Medicaid; certain UnitedHealthcare products are also excluded.^[5]

Appointments are usually 55 minutes. Cancel inside 24 hours and the practice says it charges $100.^[16]

Best for: a woman who wants a full-length RDN visit, has a non-HMO plan the practice accepts, or prefers a clear $156 self-pay fallback.

Not for you if: you need GLP-1 prescribing in the same organization, you use an HMO or Medicaid, or a $100 short-notice fee would make the schedule too risky.

Culina Health: the membership route

Punchline: Culina can work when you want recurring RDN contact and know you will use it. It becomes expensive when life interrupts.

The current membership page publishes:

• Essentials: $99 per month; one 60-minute intake in month one, then one 30-minute session per month.
• Core: $169 per month; a 60-minute intake and one follow-up in month one, then two 30-minute sessions per month.
• Enhanced: $229 per month; a 60-minute intake and one 45-minute follow-up in month one, then two 45-minute sessions per month.^[6]

There is no separate $99 initiation fee on the current page. The $99 figure is the monthly Essentials plan.

The real catches are stronger:

• Unused sessions do not carry over and are not refunded.
• A late cancellation, late reschedule, or no-show forfeits the session.
• If you cancel before completing the introductory month plus one full follow-up month, Culina reprices the care at $225 for the initial session and $100 for each follow-up, then applies your membership payments.
• Membership fees cannot be submitted to insurance for reimbursement.^[6]

Best for: someone who wants recurring RDN time, values continuity, and will use the scheduled care.

Not for you if: your calendar is unpredictable, you want a single test visit, or you need the prescriber inside the same program.

Sesame: the fast cash marketplace

Punchline: Sesame is the speed route, not the credential-guarantee route.

On September 3, 2026, The HRT Index pulled Sesame’s live “Best Online Nutritionist” listing. It showed 14 results. Nine displayed RD, RDN, or RD-LD credentials. Five were other clinician types: a chiropractor, an APRN, two nurse practitioners, and an MD. The page offered specialty filters, but its default “nutritionist” result was not dietitian-only.^[7]

That is an original live-listing snapshot, not a claim that Sesame’s roster will always contain those same people. It will change.

The tradeoff is clean: on the large insurance networks, the dietitian credential is guaranteed and the final price may not be. On Sesame, the price is visible and the credential has to be checked. Pick the certainty you need.

Best for: a fast, one-off cash consultation when you can read credential letters and choose “Nutrition & dietetics.”

Not for you if: you want a guaranteed RDN match, benefits verification, an integrated prescriber, or a menopause-trained network.

Not sure whether you need one clinic or a two-provider team?

Use The HRT Index’s Find My HRT Path tool →

It takes about 90 seconds, requires no email, keeps the answers in temporary browser memory, and shows the HRT care route that fits your symptoms, medication route, insurance, and state. A licensed clinician still makes every treatment decision.

What does a menopause dietitian for women on GLP-1 actually cost?

Answer capsule: Published per-visit cash prices currently run from $119 for a Gennev RDN follow-up to $199 for its first RDN visit. Nourish is $145 and Health Loft is $156. Fay’s uncovered estimate is closer to $150. Culina’s $99–$229 membership cannot be compared to a single visit without counting session length, rollover, and exit terms.

Platform	Model	Current published cash price	Late cancellation / no-show	Cost detail people miss
Gennev	Integrated clinic	RDN $199 initial / $119 follow-up; doctor $250 initial / $199 follow-up	$100 inside 24 hours	The integrated self-pay entry is $449 before medication and any outside lab cost
Nourish	RDN network	$145 per session	$75 inside 24 hours	Published guarantee protects prior visits if a claim is denied
Health Loft	RDN practice	$156 per session	$100 inside 24 hours	HMO and Medicaid plans are not accepted; some UHC products are excluded
Fay	RDN marketplace	Uncovered care could be closer to $150	$75 inside 24 hours or after arriving more than halfway late	Final liability still follows the plan and Fay’s financial policy
Culina Health	Membership	$99 / $169 / $229 per month	Session forfeited inside 24 hours	No rollover; early cancellation can trigger standalone repricing
Berry Street	Integrated insurance program	No single cash total published	Confirm before booking	“As low as” visit and medication prices are conditional, not guaranteed
Sesame	Cash marketplace	Shown per clinician before booking	Check the listing and current terms	No stable sitewide nutrition price
Midi Health	Menopause/weight clinician; not a separate RDN visit	$250 first / $150 return	Check current terms	Medication and labs are separate; Medicare claims cannot be submitted

Compare a course of care, not a single visit

One visit rarely resolves a changing appetite, a dose escalation, an insurance renewal, and a strength plan.

Use this arithmetic before you commit:

First visit + planned follow-ups + membership or program fees + expected lab charges + cancellation risk + medication cost = what the pathway actually costs you.

Do not let us or a platform assume a cadence for you. Ask how many visits are expected and what clinical event changes that cadence.

Gennev gives enough detail to price a common path. Its RDN-first program recommends six care visits over three months. At published self-pay rates, one $199 initial RDN visit plus five $119 follow-ups is $794. Add the required first doctor visit at $250 and the visible care total becomes $1,044, before medication and any lab bill. That is Calculated by The HRT Index from Gennev’s current published prices and stated cadence — not a required price for every patient.

Culina requires a different calculation. Its $99 Essentials plan looks cheaper than a $145 single visit, but after month one the included visit is 30 minutes, unused sessions vanish, and early cancellation can trigger standalone repricing. The sticker price is not the unit.

“Most patients pay $0” can be true and still not be your price

Nourish says 94% of in-network patients pay $0. Berry Street advertises appointments as low as $0. Fay says most people get sessions free. Health Loft says most clients are covered at 100% or owe a small share.^[2][3][4][5]

Those claims describe company experience or a conditional minimum. Your plan still controls:

• whether the clinician is in network;
• whether the diagnosis qualifies;
• whether a referral or prior authorization is required;
• whether the service is preventive counseling or medical nutrition therapy;
• whether the deductible applies;
• how many visits are allowed;
• and what happens when the benefit estimate is wrong.

Do not read a category-wide percentage as your personal quote.

Will insurance cover a dietitian while you are on a GLP-1?

Answer capsule: Sometimes — but the prescription does not automatically unlock nutrition coverage. Your GLP-1 may be prescribed for obesity, type 2 diabetes, cardiovascular-risk reduction, obstructive sleep apnea, or another approved indication. Coverage depends on the diagnosis in your record, the nutrition benefit, the clinician’s network status, referral rules, and the exact plan.

This is where the shortcut breaks.

A GLP-1 prescription does not prove that an obesity or BMI-based diagnosis is in your chart. Ozempic and Mounjaro are approved for type 2 diabetes; Wegovy, Zepbound, and Foundayo have weight-management indications; Wegovy and Zepbound also have additional labeled uses. The diagnosis attached to your prescription may help an RDN bill the visit, but it may also be a diagnosis your nutrition benefit does not cover.

Menopause alone is not a qualifying Original Medicare diagnosis for medical nutrition therapy. Under Original Medicare, the core MNT benefit is tied to diabetes, kidney disease, or a kidney transplant in the previous 36 months and requires a doctor’s referral. Initial coverage includes three hours in the first calendar year and up to two follow-up hours in each later calendar year, with more hours possible after a qualifying change and new referral.^[17]

Commercial plans are not one national rule. They may cover broader diagnoses, preventive counseling, obesity treatment, diabetes education, or other nutrition services — or they may exclude them.

Three questions that settle the coverage path

1. Ask the office that prescribes your GLP-1 which diagnosis is documented for this treatment. Do not ask them to invent a different one. Ask what is already true in your record.
2. Give that diagnosis and your exact plan to the nutrition platform. Ask it to run the benefit check against the actual clinician and service.
3. Ask whether the claim will be preventive counseling or medical nutrition therapy. Those are different benefits and can produce different cost sharing.

An RDN can make a nutrition diagnosis. That does not mean she can create a medical diagnosis solely to make an insurer pay. The medical condition and referral have to come from the appropriate licensed clinician when the plan requires them.

One thing we will not do: tell you to chase a diagnosis you do not have to unlock a benefit. The point is the opposite. Find out what is already documented and make the benefit check use the right record.

Use the questions below to verify the diagnosis, referral, network, and claim pathway before the first visit.

Ready to run the benefit check?

Start with Gennev or Berry Street if you need prescribing and nutrition inside one program. Start with Nourish, Fay, or Health Loft if you already have a responsive prescriber and want the nutrition benefit to do one job well.

If speed matters more than insurance, open Sesame’s current nutrition listing from the provider source below. Check for RD, RDN, or RD-LD beside the clinician’s name before you book.^[7]

What can put GLP-1 coverage renewal at risk?

Answer capsule: Renewal criteria are plan-specific. One current Aetna weight-management policy, for example, requires at least three months at a stable maintenance dose plus loss or maintenance of at least 5% of baseline body weight. That is not a universal rule. Your own dated policy document controls, and the record has to exist before renewal.

This is the section we would keep if we had to delete half the page.

What your plan may be looking for

Weight-management prior authorization policies commonly ask for some combination of:

• the labeled diagnosis and starting criteria;
• a baseline weight or BMI;
• a weight-related condition when the label requires one;
• documentation of diet, activity, or a comprehensive weight-management program;
• completion of a dose-escalation or maintenance period;
• evidence of response;
• continued medical necessity;
• and current chart notes.

One current Aetna weight-management policy is concrete: after at least three months at a stable maintenance dose, continuation requires documentation that the patient lost at least 5% of baseline body weight or maintained the initial 5% loss.^[18]

That is a verified example, not a category rule. Another employer plan can use different thresholds, a named lifestyle vendor, a different review interval, or an outright exclusion.

Pull the policy for your exact drug, exact plan, and current plan year. Read the review date. If the employer plan is self-funded, the logo on the card may not tell you who wrote the benefit.

Why the scale is an incomplete instrument in menopause

The Study of Women’s Health Across the Nation followed women through the menopause transition with repeated body-composition measurements. On average, the rate of fat gain doubled and lean mass began to decline at the start of the transition; those trajectories continued until about two years after the final menstrual period. Total weight, meanwhile, rose linearly without a new acceleration at the start of the transition.^[19]

That does not mean every woman’s weight and body composition move the same way. It means the scale can stay comparatively quiet while fat and lean tissue are changing underneath it.

Now put that beside a prior-authorization rule built around total body weight.

Your continued access can hinge on a number that cannot tell the insurer whether the weight lost was fat, water, or lean tissue. A woman losing fat while preserving more lean tissue may have a better physiological result and a less dramatic scale result than someone who lost both.

That is an editorial synthesis of two separate evidence streams: a carrier policy and menopause body-composition research. It does not override the policy. It tells you why the chart should contain more than a number.

What to start recording today

The appeal is won with the record, not the argument. And the record has to exist before you need it.

Keep this	Why it matters
Baseline weight and date	Continuation policies often compare against the original treatment baseline
Exact medication, start date, and dose-change dates	Shows where you are in initiation, escalation, or maintenance
Every prescriber and RDN visit date	Documents ongoing clinical and nutrition support
Program enrollment and attendance	Some policies require structured lifestyle participation
Side effects and actions taken	Shows why dose or intake plans changed
Strength or function measures your clinician uses	Adds context the scale cannot supply
Waist or body-composition measures, if clinically appropriate	Can document change beyond body weight; the insurer may or may not accept them
Policy PDF and review date	Prevents you from arguing against an obsolete criterion
Call reference numbers, portal messages, denials, and appeal deadlines	Creates the administrative record

Print that table or copy it into one note. There is no goal-weight field. That absence is deliberate.

Who owns what: dietitian, prescriber, or menopause clinician?

Answer capsule: The RDN owns nutrition assessment, food tolerance, adequacy, and the nutrition plan. The GLP-1 prescriber owns eligibility, the prescription, dose changes, serious side effects, and prior authorization. The menopause clinician owns hormone-treatment decisions. Paying the wrong person for the question is the fastest way to leave with another referral instead of an answer.

Question	Dietitian (RD/RDN)	GLP-1 prescriber	Menopause clinician
Should I start, stop, or change my GLP-1 dose?	No, unless separately licensed to prescribe and acting in that role	Yes	Only if also managing that medication
How do I eat through nausea or early fullness?	Yes, for food and fluid strategy	Evaluates severity and medication decisions	Not usually
Is severe abdominal pain or repeated vomiting a medication problem?	Escalates; does not replace evaluation	Yes — contact promptly	Can triage if she is your treating clinician
How do I protect nutrition and strength with a tiny appetite?	Yes	Supports and coordinates	Supports and coordinates
Should I use hormone therapy?	No	Only if separately qualified	Yes
Should I change an oral hormone because of a GLP-1 label?	No	Reviews the GLP-1 interaction question	Reviews the hormone route and plan
Do I need a bone-density evaluation?	Can identify risk and raise the question	Can assess or order within scope	Often the best first clinician for the menopause-specific question
Will insurance renew the drug?	Documents nutrition care and adherence	Owns the prescription and PA submission	Not usually
Am I losing muscle?	Can assess intake, function, and trends; may coordinate body-composition testing	Can order or interpret testing within scope	Can assess the broader menopause and bone context

Two practical rules fall out of this table.

A standalone dietitian is the simpler path when you already have a responsive prescriber, the medication plan is stable, and the unresolved problem is eating, tolerance, structure, strength, or maintenance.

An integrated clinic is cleaner when you still need prescribing, the side effects may change the dose, menopause symptoms and hormone questions need reviewing too, or separate clinicians have stopped communicating.

And the boundary worth saying out loud: a dietitian is not a substitute for your prescriber. That separation can also be the advantage. Because the RDN is not spending the visit deciding whether to prescribe, she can spend the hour on the tissue and nutrition you are trying to keep.

How much muscle do you actually lose on a GLP-1?

Answer capsule: In the SURMOUNT-1 body-composition substudy, about 75% of weight lost with tirzepatide was fat mass and about 25% was lean mass. Lean mass is not the same as muscle: it also includes water, organs, glycogen, and connective tissue. The percentage is a study average, not a forecast for your body.

Two corrections before the number, because both are used to frighten women.

First: lean mass is not muscle. A DXA “lean mass” result contains skeletal muscle, but it also contains water, glycogen, organs, and other non-fat, non-bone tissue. Converting every pound of lean-mass change into “muscle lost” is inaccurate.

Second: losing some lean tissue is not unique to GLP-1 treatment. Substantial weight loss by diet, medication, or surgery can include both fat and lean tissue. The clinically useful question is not whether the lean compartment moves at all. It is what you can do to preserve strength, function, and as much muscle as possible while treating the condition that made the medication appropriate.

In the SURMOUNT-1 DXA substudy, roughly 75% of the weight lost with tirzepatide was fat mass and roughly 25% was lean mass. The proportions were similar by age and sex in that substudy.^[20]

Some pages turn the STEP 1 DXA result into a “toward 40% muscle loss” claim. We do not. The analysis reported a decline in lean mass, but converting that result into a clean muscle-loss percentage creates exactly the confusion this section is trying to stop.

The part that is specific to menopause

The pivotal GLP-1 weight-loss trials were not designed around menopause stage.

SWAN found that, on average, lean mass begins declining at the start of the menopause transition while fat gain accelerates.^[19] A woman who starts a GLP-1 during that window may therefore be managing two overlapping pressures on body composition.

That is not a reason to fear or stop an effective medication. It is the reason the nutrition and strength plan cannot be an afterthought.

What the evidence supports doing

The four-society advisory is direct: manage gastrointestinal symptoms, prevent nutrient deficiency, and preserve muscle and bone through resistance training and an appropriate diet.^[10]

The exact program has to fit the person. An RDN can build the intake side. A qualified exercise professional or clinician can adapt training around pain, injury, balance, and current capacity. “Lift weights” is not a complete prescription when somebody has never trained, has pelvic-floor symptoms, or cannot tolerate enough food to recover.

What does GLP-1 treatment mean for bone during menopause?

Answer capsule: Menopause-related bone loss begins about one year before the final menstrual period and is fastest around the transition. Weight loss can add another bone stressor. Small trials show that GLP-1 treatment and weight loss can lower bone density in some settings, while supervised exercise can protect it. Fracture risk and menopause-specific outcomes remain less certain.

This is the layer most pages skip, and it is the one where when you are doing this changes the question.

Four findings, stacked honestly

What is happening	What the evidence found	What it does not prove
Menopause is already changing bone	In SWAN, spine and femoral-neck bone loss began about one year before the final period and decelerated, but did not stop, about two years after it[21]	That every woman needs a DXA scan or medication
Menopause is already changing body composition	Fat gain accelerated and lean mass declined from the start of the transition to about two years after the final period[19]	That the same change happens at the same rate in every woman
Semaglutide produced a bone-density signal in a high-risk trial	A 52-week phase 2 trial of 64 adults at increased fracture risk using semaglutide 1.0 mg found higher bone resorption and lower hip and spine BMD than placebo, without a rise in the primary bone-formation marker[22]	The result of current obesity-dose injectable or oral Wegovy in an average menopausal woman
Exercise changed the outcome in a randomized trial	In adults with obesity, supervised exercise preserved bone density; liraglutide alone lowered hip and spine BMD, while the combination produced more weight loss without the same bone loss[23]	That the exact program or result automatically transfers to every menopausal GLP-1 user

That last row is the most useful randomized finding here.

Do not call that intervention a resistance-training arm. It was a supervised exercise program, and that distinction matters. A good finding does not need to be upgraded into a different one.

Two things that keep this honest

Lower bone density is not the same as a fracture. BMD is a surrogate outcome. Fracture is the event you actually care about, and current observational evidence does not support a simple claim that GLP-1 medication universally raises fracture risk.

The trials are small, short, and not menopause-transition trials. The semaglutide study enrolled adults already at increased fracture risk and used 1.0 mg weekly. The exercise trial used liraglutide in adults aged 18–65 with obesity and no diabetes. Neither trial was built to answer this exact search.

The responsible conclusion is not “GLP-1s destroy bone.” It is this:

If rapid loss, low intake, menopause timing, prior fracture, low body weight, steroid exposure, or another risk factor puts bone on your list, the question deserves a clinician — and exercise belongs in the conversation.

Ask whether a baseline bone-risk assessment or DXA scan makes sense for your age, menopause stage, history, medications, rate of loss, and fracture risk. That is a question, not a blanket recommendation.

Do GLP-1 medications affect hormone therapy?

Answer capsule: No current US label says that a GLP-1 makes menopausal hormone therapy ineffective. Tirzepatide and Foundayo carry explicit instructions for oral hormonal contraceptives; oral Wegovy must be separated from other swallowed medicines by at least 30 minutes. Menopausal oral hormones are not directly studied in these labels. Patches, gels, sprays, and vaginal products bypass gastrointestinal absorption.

We read the current US prescribing information because the answer changed in 2026.

“GLP-1” is no longer one administration pattern. There are injections, an oral semaglutide product, and the newly approved oral GLP-1 orforglipron. The label question depends on which drug and which route you take.

Medication	Current label issue for swallowed medicines	Oral hormonal contraceptive instruction	Menopausal hormone therapy evidence
Zepbound / Mounjaro (tirzepatide injection)	Delays gastric emptying; effect is greatest after the first dose and diminishes over time	Switch to a non-oral method or add a barrier method for 4 weeks after starting and 4 weeks after each dose increase	Lilly says use with oral hormone replacement therapy has not been studied; no label instruction tells patients to change menopausal HRT
Wegovy injection (semaglutide)	Delayed gastric emptying may affect oral medicines; monitor medicines that depend on threshold concentrations or clinical/lab monitoring	No equivalent named warning in the US Wegovy label	No specific menopausal-HRT instruction
Wegovy tablets (oral semaglutide)	Take on an empty stomach with up to 4 ounces of water and wait at least 30 minutes before food, drink, or other oral medicine	No separate oral-contraceptive warning in the current label	No specific menopausal-HRT instruction; the 30-minute administration rule applies to other swallowed medicines
Foundayo (orforglipron tablets)	Delays gastric emptying and can affect other oral medicines	Use a non-oral method or add a barrier method for 30 days after starting and 30 days after each dose escalation	No specific menopausal-HRT instruction in the current label

Source: current Zepbound,^[24] Wegovy,^[25] and Foundayo prescribing information,^[26] plus Lilly’s medical-information response on tirzepatide and hormone replacement therapy.^[27]

What this means — and what it does not

It does not mean GLP-1 medication has been shown to make menopausal hormone therapy fail. That study has not been done for tirzepatide, and the labels do not establish that claim for menopausal HRT.

What is known is narrower:

• Tirzepatide and Foundayo have explicit contraceptive instructions.
• Oral Wegovy has an explicit administration interval before other oral medicines.
• Injectable semaglutide has broader monitoring language for oral drugs.
• No current label gives a menopause-specific dose-change rule for estradiol or progesterone.

If your estrogen is delivered through a patch, gel, spray, vaginal tablet, cream, or ring, it bypasses the stomach. The delayed-gastric-absorption mechanism does not apply to that route. That does not prove there can never be any interaction of any kind; it answers this specific mechanism.

If you swallow estradiol or progesterone while starting or increasing tirzepatide, beginning Foundayo, or taking oral Wegovy, ask one focused question:

“My hormone therapy is oral, and my GLP-1 has instructions about swallowed medicines or oral hormones. Do you want me to separate the doses, monitor anything, or keep the plan unchanged?”

Do not switch, stop, or re-route hormone therapy on your own.

One place this is not theoretical: if you are in perimenopause and still use an oral hormonal contraceptive, the tirzepatide and Foundayo instructions are explicit. Follow the current label and your prescriber’s advice. Read Low-Dose Birth Control for Perimenopause for the contraception decision itself.

When do GLP-1 side effects and menopause symptoms look alike?

Answer capsule: Fatigue, constipation, reflux, poor sleep, appetite changes, and hair shedding can overlap. Timing is the first clue: symptoms that begin or spike after starting or increasing the drug deserve medication review; hot flashes and cycle-linked symptoms point elsewhere. Severe, persistent, or worsening symptoms are not a nutrition puzzle and should not wait for an RDN visit.

Symptom	Common GLP-1 connection	Menopause connection	What helps separate them
Nausea / early fullness	Common, especially during initiation or dose escalation	Not a classic menopause symptom	Does it track the medication start or dose increase?
Constipation	Common	Can occur in midlife for many reasons	Did it begin or worsen with treatment, reduced intake, or lower fluid?
Reflux / heartburn	Can occur	Also reported in midlife	Track timing against the medication start, dose escalation, meals, and sleep
Bloating	Can occur	Also common in midlife	Medication timing, constipation, and food tolerance matter
Fatigue / brain fog	Can follow low intake, dehydration, sleep disruption, or another medical problem	Common complaints in the transition	Do not assume either cause; ask whether evaluation or labs are appropriate
Poor sleep	Symptoms, reflux, or nausea can disrupt it	Very common, especially with night sweats	Nighttime vasomotor symptoms point toward menopause care
Hair shedding	Can follow rapid weight loss or inadequate intake	Can also occur in midlife	Timing, rate of loss, iron status, thyroid status, and other causes need review

The one we would push you on

Fatigue and brain fog are often assigned to hormones by default.

Perimenopausal bleeding can be heavy or prolonged. Appetite suppression can also reduce iron-rich intake. That makes iron deficiency one plausible explanation among several — not a diagnosis.

Ask your clinician whether a CBC, ferritin, or other evaluation is appropriate. Do not start iron just because an article suggested it. Heavy, prolonged, or unusual bleeding needs its cause assessed; postmenopausal bleeding needs prompt clinical evaluation.

Stop reading and contact a clinician if you have

• severe or persistent abdominal pain;
• repeated vomiting or signs of dehydration;
• symptoms that are rapidly worsening;
• new bleeding after menopause;
• rapid, unintended weight loss;
• or any symptom your prescribing information tells you requires urgent evaluation.

None of those is a food-plan problem. An RDN can support recovery and intake after the medical issue is assessed. She should not delay the assessment.

What should happen in the first dietitian appointment?

Answer capsule: A strong first visit should document the medication, dose stage, menopause stage, appetite, gastrointestinal tolerance, medical history, labs, strength or function, goals beyond weight, insurance constraints, and communication plan with the prescriber. You should leave with two or three workable priorities and clear escalation triggers — not a template meal plan and fifteen new rules.

What to bring

• Every medication and supplement, plus who prescribed each one
• GLP-1 start date, current product, current dose, and clinician-directed dose-change dates
• The current prescribing information or medication guide if you have questions
• Notes on nausea, fullness, bowel pattern, reflux, food aversion, thirst, and what you can tolerate
• A realistic few days of eating — do not perform a perfect week first; it defeats the point
• Relevant labs and bone-density results
• Hormone-therapy status and route: patch, pill, gel, spray, vaginal product, or none
• Insurance details and a referral when the plan requires one
• Current strength training, injuries, falls, or mobility limits
• Goals beyond weight
• Any history of restrictive eating, binge eating, purging, compulsive exercise, or unsafe tracking you feel able to share

What you should leave with

• Two or three priorities. Not fifteen.
• A plan for eating enough within what you can tolerate
• A strategy for fluid, constipation, nausea, or other ordinary nutrition barriers
• A resistance-training or referral plan appropriate to your ability
• A way to monitor adequacy, symptoms, strength, and function over time
• A written trigger for when the question returns to your prescriber
• Follow-up cadence and price before the next booking
• The diagnosis and service category the claim will use
• A denial plan
• Permission to drop tracking tools that are harming your relationship with food

Signs the visit was too generic

You have a right to judge this.

• A template meal plan appears before anyone asks about your medication, stage, history, or tolerance.
• One protein number is presented as correct for everyone.
• Nobody asks which GLP-1 you use or where you are in dose escalation.
• Nobody asks about eating-disorder history or unsafe tracking.
• Weight is recorded reflexively with no explanation of why it is being used.
• Hot flashes are sold as something food will fix.
• The RDN has no plan to communicate serious symptoms or medication concerns back to the prescriber.

If you get two or more of those, you paid for a handout. Ask for a different clinician or use the platform’s transfer process.

“I LOVE my dietitian. She designed a customized plan for me and kept me accountable. My sessions were FREE because insurance paid for it.” — Kelly O., testimonial published by Fay^[32]

Provider-published testimonial; not independently verified by The HRT Index. It does not establish typical cost or clinical results. Insurance coverage varies by plan.

What happens if you stop the GLP-1?

Answer capsule: Regain after stopping is common, but no honest dietitian can promise to prevent it. In the STEP 1 extension, participants regained about two-thirds of their prior semaglutide-related weight loss during the year after withdrawal. Tirzepatide withdrawal trials also found substantial regain. The useful question is what support, strength, and eating structure remain when treatment changes.

Two honest things about that.

It is not a reason to fear the medication. Obesity and related conditions are chronic, access changes, side effects happen, plans exclude drugs, and people make different treatment decisions with their clinicians.

It is not a reason to feel like you failed if treatment stops. The biology does not become a character test because an insurance plan changed.

In the STEP 1 trial extension, participants regained about two-thirds of their prior weight loss during the year after semaglutide withdrawal.^[28] In SURMOUNT-4, withdrawing tirzepatide led to substantial regain while continued treatment maintained and added to the prior loss.^[29]

A dietitian cannot guarantee maintenance. She can help you build the part that does not come in a pen:

• strength and function;
• a tolerable eating structure;
• a plan for hunger returning;
• a way to monitor nutrition without turning life into a spreadsheet;
• and a handoff back to the prescriber before coverage or medication disappears.

That is the strongest argument for bringing the RDN in early rather than waiting for the last refill.

If the hormone side is the bigger half

Midi Health can evaluate menopause symptoms and weight care in one clinician-led visit, order selected labs, and prescribe when appropriate. It does not publish a separately bookable RDN visit on the current pages we reviewed.

Midi’s self-pay visits are $250 initially and $150 for returns. It accepts many commercial plans, but Medicare is out of network and beneficiaries cannot submit Midi-related claims; Medicaid and Medi-Cal are not accepted.^[8]

Midi publishes both FDA-approved and compounded GLP-1 pathways. Compounded medications are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality. If that distinction fits your decision, check your plan and state availability on Midi →.

What should you verify before you pay?

Answer capsule: Four things determine whether the appointment is worth the money: the clinician’s credential, authorization to see you where you are physically located, the price and cancellation terms on the booking path, and the diagnosis and service your insurer will process. Verify all four before the card is charged — not after the first claim returns.

1. Verify the credential

RD and RDN are two designations for one Commission on Dietetic Registration certification program. A credentialed practitioner may choose either.^[30]

That is different from the word “nutritionist.” State title and practice laws vary, and the word by itself does not establish an RD/RDN credential, training level, or authority to deliver medical nutrition therapy.

Use the Commission on Dietetic Registration’s credential lookup. Then check the relevant state licensing board when the state regulates dietetic practice.

The Menopause Society’s directory can add another layer. An RDN may hold the Menopause Society Certified Practitioner credential, but that is not required to be a competent menopause dietitian. What matters is whether the actual clinician has relevant education, experience, and a care plan that respects scope.

The credential letters belong to the person, not the platform. Verify the individual before the visit.

2. Verify the state where you will sit for the visit

Telehealth rules follow the patient’s physical location and the clinician’s authority to practice there. A platform’s national footprint does not mean every listed dietitian can see you in every state.

Ask:

“Are you licensed or otherwise authorized to provide this visit while I am physically in [state]?”

Ask again before a trip. A clinician who can see you at home may not be able to see you while you are temporarily somewhere else.

3. Save the quoted price and terms

Take a screenshot of:

• the clinician and credential;
• the appointment type and duration;
• the price or benefit estimate;
• the cancellation window;
• the no-show fee;
• whether unused sessions expire;
• whether a membership renews automatically;
• and what happens if insurance denies the claim.

This is not paranoia. The comparison already contains prices that only settle after a benefit check, marketplace prices that change by clinician, and a membership that reprices early cancellation.

4. Ask these questions before paying

1. Are you an RD or RDN, and can I verify the credential?
2. Are you authorized to see me while I am physically in my state?
3. How much work have you done with women in perimenopause or menopause who use GLP-1 medication?
4. Who owns prescribing and dose changes?
5. Will you send a note to my prescriber?
6. Which diagnosis and service code will this visit use?
7. Will the claim process as preventive counseling, medical nutrition therapy, or something else?
8. What do I owe if the benefit estimate is wrong?
9. What is the late-cancellation or no-show fee?
10. Do unused sessions expire or roll over?
11. Can we work without routine weighing if that is safer for me?
12. What symptom sends me back to the prescriber immediately?

The insurance call, word for word

“I want to verify outpatient nutrition counseling or medical nutrition therapy by telehealth. Is [clinician name and NPI] in network for my exact plan? Which diagnoses qualify? Is a referral or prior authorization required? Does my deductible apply? What is my copay or coinsurance? How many visits are allowed? What CPT codes should the provider use? Can I have a reference number for this call?”

That last question is the one people forget. It is the one that matters when the claim comes back differently.

When is a dietitian the wrong first call?

Answer capsule: A dietitian is the wrong first call when the problem needs medical evaluation, urgent hydration or pain assessment, medication adjustment, postmenopausal bleeding work-up, or eating-disorder treatment beyond outpatient nutrition counseling. The right RDN will recognize that boundary and help connect the handoff instead of treating every symptom as a meal-plan problem.

Go to your prescriber, gynecology clinician, primary-care clinician, urgent care, or emergency service as appropriate if you have:

• severe or persistent abdominal pain;
• repeated vomiting or signs of dehydration;
• new bleeding after menopause;
• heavy or unusual bleeding;
• rapid unintended weight loss;
• fainting, confusion, or another acute change;
• or a symptom the medication guide tells you needs urgent attention.

If you have a history of disordered eating

This deserves saying directly.

A medication that suppresses appetite, an insurer that may reward a falling number, and a care platform built around weight can be a dangerous combination for somebody whose eating disorder is active or easily reactivated.

The four-society advisory places screening for disordered eating in the baseline assessment.^[10] That is not a footnote. It belongs before the plan.

Ask the clinician:

• Do you practice weight-inclusively?
• Will you work with me without weighing me?
• What would make you involve an eating-disorder specialist?
• Will you ask permission before introducing calories, macros, food logging, exercise targets, or weight tracking?
• How do you coordinate with a therapist, physician, and eating-disorder-informed RDN?

Those questions will sort clinicians faster than a glossy “women’s wellness” page.

Support is available: the National Alliance for Eating Disorders operates a free helpline answered by licensed therapists and other mental-health professionals. Call 866-662-1235, Monday through Friday, 9 a.m. to 7 p.m. Eastern, or leave a message outside those hours.^[31] The helpline can connect callers to treatment resources; it does not diagnose or provide medical advice by phone.

How did The HRT Index verify this comparison?

Answer capsule: This page is independent editorial research, not clinical review. We read current provider service pages, price pages, billing terms, cancellation policies, FDA prescribing information, medical-society guidance, CMS coverage materials, and primary research. Commercial facts were checked September 1–3, 2026. Provider claims remain provider-stated unless a separate source independently establishes them.

What we actually verified

What	How	Last checked
Gennev’s GLP-1 prescribing, RDN-first pathway, visit cadence, labs, menopause training, carrier list, and self-pay prices	Current Gennev weight-management page	September 3, 2026
Gennev’s $100 late-cancellation fee	Current Gennev support policy, last updated March 18, 2026	September 3, 2026
Berry Street’s clinician + RDN model, FDA-approved-only formulary, insurance language, national footprint, and conditional pricing	Current GLP-1 program page	September 3, 2026
Nourish’s $145 self-pay price, 94% in-network statistic, Medicare referral diagnoses, and billing guarantee	Current insurance and billing FAQs	September 3, 2026
Nourish’s $75 late-change fee and Medicaid exclusion	Current policy FAQs	September 3, 2026
Fay’s RD/RDN-only platform claim, 700+ plan claim, and uncovered-price wording	Current pricing page	September 3, 2026
Fay’s financial responsibility and $75 late-cancellation terms	Current policies	September 3, 2026
Health Loft’s $156 self-pay rate, plan exclusions, and $100 late-cancellation fee	Current billing FAQ and consent	September 3, 2026
Culina’s $99/$169/$229 memberships, no-rollover term, session forfeiture, and early-exit repricing	Current membership page	September 3, 2026
Sesame’s listing composition	Live manual count of all 14 current results and visible credentials	September 3, 2026
Midi’s current visit prices, insurance limits, GLP-1 pathway, and absence of a separately bookable RDN service on reviewed pages	Current weight-management and pricing pages	September 3, 2026
Zepbound, Wegovy injection/tablet, and Foundayo label instructions	Current FDA-approved US prescribing information	September 3, 2026
Muscle, bone, menopause-body-composition, exercise, and discontinuation claims	Primary peer-reviewed papers and medical-society guidance	September 3, 2026

Provider-stated versus verified

Label	Meaning on this page
Provider-stated	The company publishes the claim about its own service
Verified by The HRT Index	We located the current source, read it, and recorded the date
Calculated by The HRT Index	We performed transparent arithmetic using published figures
Editorial conclusion	Our fit judgment based on the verified facts
Not publicly established	We looked for the fact and did not locate a reliable current public answer
Confirm at intake	The fact depends on your clinician, state, plan, checkout, or treatment decision

Verification does not turn a provider’s marketing claim into independent clinical evidence. When Berry Street says it accepts 1,250+ plans, that is a verified provider-stated number: we verified that the company currently publishes it. We did not audit 1,250 plan contracts.

The HRT Index Verification Standard

The HRT Index Verification Standard is our documented process: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule — top providers monthly, the full roster quarterly.

We evaluate providers on five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, access.

We do not publish numeric provider scores on this page. A number would compress the exact tradeoffs you came here to see.

FDA-approved and compounded are kept separate

FDA-approved drugs have been reviewed for the approved use under a specific application, labeling, manufacturing, and quality framework. Compounded drugs are not FDA-approved and do not undergo that premarket review. FDA has also reported dosing errors and adverse events associated with compounded injectable semaglutide and tirzepatide and advises patients to use state-licensed pharmacies.^[9]

A compounded prescription may be legally appropriate for an identified patient under applicable law when a clinician determines the approved product cannot meet that patient’s medical need. That does not make it a generic equivalent, interchangeable copy, or safer option.

What still belongs to you and your clinician

We verified published pathways. You still have to confirm:

• whether the assigned clinician has the dual experience you need;
• whether the clinician may legally see you in your state;
• whether your plan is in network;
• whether your diagnosis and service qualify;
• your actual copay, deductible, or self-pay total;
• medical eligibility for any prescription;
• the FDA-approved or compounded status of the exact medication offered;
• current appointment availability;
• and the total cost of the expected care course.

Found something wrong? Contact The HRT Index. We publish the correction date and the field that changed.

Frequently asked questions

Do I need a dietitian if I am already on a GLP-1?

Not automatically. The strongest reasons are persistent gastrointestinal barriers, very low intake, muscle or bone concern, rapid loss, a complicated medical history, an eating-disorder history, or a prescriber visit that never has time for nutrition. The 2025 four-society advisory lists RDN counseling as a supportive strategy, not a mandate for every patient.^[10]

Which menopause dietitian is best for women on GLP-1 medication?

Gennev is the clearest menopause-trained integrated clinic because it publishes a coordinated RDN, doctor, lab, and GLP-1 pathway. Berry Street is the strongest insurance-first integrated alternative and says it prescribes FDA-approved GLP-1 medications only. When you already have a responsive prescriber, Nourish, Fay, Health Loft, Culina, or an appropriately credentialed Sesame clinician may be enough.

Will insurance cover a dietitian while I am on a GLP-1?

It may. The prescription itself does not guarantee coverage or prove which diagnosis is in your chart. Ask the prescriber which diagnosis supports the treatment, then ask the nutrition provider and insurer whether that diagnosis, clinician, telehealth service, and code are covered under your exact plan.

Does menopause itself qualify for medical nutrition therapy?

Commercial plans vary. Under Original Medicare, menopause is not one of the qualifying MNT diagnoses; eligibility is tied to diabetes, kidney disease, or a kidney transplant in the previous 36 months and requires a doctor’s referral. A commercial plan may cover broader preventive or medical nutrition services, but its current plan document controls.^[17]

Can a dietitian prescribe or change my GLP-1 dose?

Not while acting only under an RD/RDN credential. Some individuals also hold a prescribing license, but that is a separate professional role. The integrated program should tell you which clinician owns the prescription, dose changes, side-effect evaluation, and prior authorization.

Can I use hormone therapy and a GLP-1 at the same time?

No current US label broadly prohibits menopausal hormone therapy with a GLP-1. Tirzepatide and Foundayo have explicit oral-contraceptive instructions, oral Wegovy must be separated from other oral medicines by at least 30 minutes, and menopausal oral hormones are not directly addressed by a specific dose-change rule. Ask the prescriber before changing anything.^{[24][25][26][27]}

Does a GLP-1 change how estrogen is absorbed?

The answer depends on the route. A patch, gel, spray, or vaginal estrogen product bypasses the stomach, so delayed gastric emptying does not affect absorption through that mechanism. For swallowed estradiol or progesterone, no label provides a menopause-specific adjustment; ask the clinician who manages the hormone and the GLP-1.

How much muscle do women lose on a GLP-1?

No study gives one menopause-specific percentage. In the SURMOUNT-1 DXA substudy, roughly 25% of weight lost with tirzepatide was lean mass and 75% was fat mass. Lean mass is not the same as muscle, and the average does not predict an individual woman’s result.^[20]

Do GLP-1 medications cause bone loss?

Weight loss can affect bone, and small trials have found lower BMD with semaglutide or liraglutide in specific populations. A randomized exercise trial found that supervised exercise preserved bone density better than liraglutide alone. Those trials were not menopause-transition trials and do not prove a universal fracture effect.^[22][23]

How much protein should a menopausal woman on a GLP-1 eat?

There is no responsible universal number. It depends on body size, kidney function, health conditions, current intake, activity, medication stage, food pattern, and tolerance. A dietitian who gives a target should be able to explain what information produced it and how the plan changes if you cannot meet it.

Is a nutritionist the same as a dietitian?

No. RD and RDN are two designation options for one Commission on Dietetic Registration certification program. “Nutritionist” alone does not verify that credential, and state title and practice laws vary. Check the person, not the marketing label.^[30]

Why did my weight stall while my clothes kept changing?

During the menopause transition, SWAN found that fat gain accelerated and lean mass declined while total weight did not show a new acceleration at the transition. Body composition can therefore shift underneath a less dramatic scale trend. Medication response, fluid, intake, and other causes still need individual review.^[19]

Can a dietitian help with hot flashes?

A dietitian can support overall nutrition and cardiometabolic health, but food should not be sold as a proven hot-flash treatment. The Menopause Society’s 2023 nonhormone statement does not recommend dietary modification, soy foods, soy extracts, or equol for vasomotor symptoms.^[11]

Can a dietitian help with nausea or constipation from a GLP-1?

Yes, with the ordinary nutrition side: identifying tolerable foods, pacing intake, planning fluids and fiber, and coordinating changes with the prescriber. Severe, persistent, or worsening symptoms, repeated vomiting, dehydration, or significant abdominal pain need medical evaluation and should not wait for a nutrition visit.

What happens if I stop taking the GLP-1?

Regain is common after withdrawal. STEP 1 participants regained about two-thirds of their prior semaglutide-related loss over the following year, and tirzepatide withdrawal also produced substantial regain. An RDN can help build a sustainable plan, but nobody can guarantee maintenance after treatment changes.^[28][29]

Are compounded GLP-1 medications the same as FDA-approved ones?

No. Compounded drugs are not FDA-approved, are not generic equivalents, and do not undergo FDA premarket review for safety, effectiveness, or quality. Ask for the exact product, dose units, pharmacy, storage instructions, and approved-versus-compounded status in writing before paying.^[9]

What if I have a history of an eating disorder?

Tell the clinician which weighing, tracking, restriction, exercise, or weight-loss language is unsafe. Ask whether the RDN works weight-inclusively, can treat you without routine weighing, and coordinates with eating-disorder specialists. Appetite suppression and insurance pressure are reasons to strengthen the safety plan, not hide the history.

Where do you go from here?

You came here worried you were doing something to your body that you could not see.

Here is what we would actually tell a friend.

The lean-mass number is real and less simple than the headline. The bone question is worth bringing forward because menopause timing and weight loss can overlap. The insurance door may be open, but the prescription alone does not prove it. And the hormone-absorption question has different answers for tirzepatide, injectable semaglutide, oral Wegovy, and Foundayo.

Three steps, in order:

1. Pick your lane. Menopause-trained integrated clinic, insurance-first FDA-approved integrated program, standalone RDN network, membership, or fast cash marketplace.
2. Verify before you pay. Credential, state, price, cancellation terms, diagnosis, service category, and prescriber handoff.
3. Start the record now. Do not reconstruct baseline dates, visits, program participation, symptoms, and policy requirements under a renewal deadline.

Still not sure which HRT program is right for you?

Take The HRT Index’s free 90-second matching quiz.

The HRT Index’s Find My HRT Path tool matches your symptoms, stage, medication route, insurance, and state to the right HRT care route — and flags when online care is not the right starting point. No email is required, and a licensed clinician makes every treatment decision.

Related reading: Midlife Weight Care and GLP-1s in Menopause · Low-Dose Birth Control for Perimenopause · Find My HRT Path

Sources

¹ Gennev, Weight Management and Online Menopause Care, accessed September 3, 2026.

² Berry Street, GLP-1 Program, accessed September 3, 2026.

³ Nourish, Does My Insurance Cover Nutrition Counseling? and Online Nutrition Care, accessed September 3, 2026.

⁴ Fay, Get Your Price and Refer a Patient, accessed September 3, 2026.

⁵ Health Loft, Insurance & Billing FAQs, Conditions, and Locations, accessed September 3, 2026.

⁶ Culina Health, Membership and About Culina Health, accessed September 3, 2026.

⁷ Sesame, Online Nutrition Consult, live listing counted September 3, 2026.

⁸ Midi Health, Weight Management and Pricing & Insurance, accessed September 3, 2026.

⁹ US Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, current through May 31, 2026; accessed September 3, 2026.

¹⁰ Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. Obesity (Silver Spring). 2025;33(8):1475–1503.

¹¹ The Menopause Society. The 2023 nonhormone therapy position statement. Menopause. 2023;30(6):573–590.

¹² Gennev, No-Show Policy for Appointments, updated March 18, 2026; accessed September 3, 2026.

¹³ Nourish, Cancellation and Rescheduling Policy, accessed September 3, 2026.

¹⁴ Nourish, Do You Accept Medicaid?, accessed September 3, 2026.

¹⁵ Fay, Policies, accessed September 3, 2026.

¹⁶ Health Loft, Consent and Practice Policies, accessed September 3, 2026.

¹⁷ Medicare.gov, Medical Nutrition Therapy Services, accessed September 3, 2026.

¹⁸ Aetna, Weight-Loss GIP/GLP-1 and GLP-1 Agonists Prior Authorization With Limit, accessed September 3, 2026. Individual plan documents may differ.

¹⁹ Greendale GA, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865.

²⁰ Look M, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study. Diabetes Obes Metab. 2025.

²¹ Greendale GA, et al. Bone mineral density loss in relation to the final menstrual period. J Bone Miner Res. 2012;27(1):111–118.

²² Hansen MS, et al. Once-weekly semaglutide versus placebo in adults with increased fracture risk. eClinicalMedicine. 2024;72:102624.

²³ Jensen SBK, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment. JAMA Network Open. 2024;7(6):e2416775.

²⁴ Eli Lilly, Zepbound (tirzepatide) US Prescribing Information, current label accessed September 3, 2026.

²⁵ Novo Nordisk, Wegovy (semaglutide injection and tablets) US Prescribing Information, current label accessed September 3, 2026.

²⁶ Eli Lilly, Foundayo (orforglipron) US Prescribing Information, current label accessed September 3, 2026.

²⁷ Eli Lilly Medical Information, Can Zepbound (tirzepatide) be used with oral contraceptives or hormone replacement therapy?, accessed September 3, 2026.

²⁸ Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553–1564.

²⁹ Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: SURMOUNT-4. JAMA. 2024;331(1):38–48.

³⁰ Commission on Dietetic Registration, Use and Misuse of CDR Credentials and Credential Verification, accessed September 3, 2026.

³¹ National Alliance for Eating Disorders, What Happens When I Call an Eating Disorder Helpline?, helpline details accessed September 3, 2026.

³² Fay, provider-published testimonial attributed to Kelly O., accessed September 3, 2026.